Takeaway
- In heavily pre-treated high-grade glioma (HGG) paediatric patients, oncolytic HSV-1 G207, alone or combined with radiation, is safe and tolerable.
- Overall survival data are promising: the survival of one third of treated patients exceeded life expectancy for newly diagnosed paediatric HGG.
- A Phase 2 trial of G207 with radiation...